|
GB929401A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Encapsulated emulsions and processes for their preparation
|
|
GB929405A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Processes for the encapsulation of particles
|
|
GB969808A
(en)
|
1962-06-08 |
1964-09-16 |
Boots Pure Drug Co Ltd |
Anthelmintic compositions and compounds
|
|
IT1148784B
(it)
|
1980-04-09 |
1986-12-03 |
Eurand Spa |
Procedimento per la preparazione di microcapsule in un veicolo liquido
|
|
US4794000A
(en)
|
1987-01-08 |
1988-12-27 |
Synthetic Blood Corporation |
Coacervate-based oral delivery system for medically useful compositions
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
US4997652A
(en)
|
1987-12-22 |
1991-03-05 |
Visionex |
Biodegradable ocular implants
|
|
US4991920A
(en)
|
1988-12-27 |
1991-02-12 |
Andrzej Peczalski |
Optical converter
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5441722A
(en)
|
1994-02-18 |
1995-08-15 |
Merck & Co., Inc. |
Short synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-[C3 H3 ]-4[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide and related non radioactive compounds
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
WO1996020698A2
(en)
|
1995-01-05 |
1996-07-11 |
The Board Of Regents Acting For And On Behalf Of The University Of Michigan |
Surface-modified nanoparticles and method of making and using same
|
|
US5624677A
(en)
|
1995-06-13 |
1997-04-29 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
|
US6566406B1
(en)
|
1998-12-04 |
2003-05-20 |
Incept, Llc |
Biocompatible crosslinked polymers
|
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6841617B2
(en)
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
|
US6632457B1
(en)
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6818018B1
(en)
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
|
US20040258763A1
(en)
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
ATE537845T1
(de)
|
2000-10-31 |
2012-01-15 |
Pr Pharmaceuticals Inc |
Verfahren zur herstellung von formulierungen zur verbesserten abgabe von bioaktiven molekülen
|
|
GB0122318D0
(en)
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
US7060299B2
(en)
|
2002-12-31 |
2006-06-13 |
Battelle Memorial Institute |
Biodegradable microparticles that stabilize and control the release of proteins
|
|
WO2004084819A2
(en)
*
|
2003-03-19 |
2004-10-07 |
University Of Kentucky Research Foundation |
Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
|
|
GB0307011D0
(en)
|
2003-03-27 |
2003-04-30 |
Regentec Ltd |
Porous matrix
|
|
TWI377958B
(en)
|
2003-06-26 |
2012-12-01 |
Control Delivery Sys Inc |
In-situ gelling drug delivery system
|
|
US20090148527A1
(en)
|
2007-12-07 |
2009-06-11 |
Robinson Michael R |
Intraocular formulation
|
|
EP1713514B1
(en)
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US7771742B2
(en)
*
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
KR20080059175A
(ko)
*
|
2005-09-07 |
2008-06-26 |
사우스웨스트 리서치 인스티튜트 |
방출속도가 향상된 생분해성 미립자 약제학적 제제
|
|
US7501179B2
(en)
|
2005-12-21 |
2009-03-10 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
|
WO2007076358A1
(en)
|
2005-12-23 |
2007-07-05 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
US8663674B2
(en)
|
2006-01-13 |
2014-03-04 |
Surmodics, Inc. |
Microparticle containing matrices for drug delivery
|
|
US20080166411A1
(en)
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
|
ATE498393T1
(de)
|
2006-09-08 |
2011-03-15 |
Univ Johns Hopkins |
Zusammensetzungen zur transportintensivierung durch die schleimhaut
|
|
GB0619869D0
(en)
|
2006-10-07 |
2006-11-15 |
Regentec Ltd |
Porous particles
|
|
AR063621A1
(es)
|
2006-11-09 |
2009-02-04 |
Alcon Res Ltd |
Matriz polimerica insoluble en agua para la administracion de farmacos
|
|
GB0701896D0
(en)
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
|
WO2008097581A1
(en)
|
2007-02-06 |
2008-08-14 |
Incept, Llc |
Polymerization with precipitation of proteins for elution in physiological solution
|
|
WO2008157614A2
(en)
|
2007-06-21 |
2008-12-24 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
CN101081206A
(zh)
*
|
2007-06-29 |
2007-12-05 |
济南康泉医药科技有限公司 |
一种含酪氨酸激酶抑制剂的抗癌药物组合物
|
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
|
US8268342B2
(en)
|
2007-10-26 |
2012-09-18 |
National Institute Of Immunology |
Biodegradable polymer scaffold and process for preparation thereof
|
|
US20090203709A1
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
|
|
US9114070B2
(en)
|
2008-02-29 |
2015-08-25 |
Nagoya Industrial Science Research Institute |
Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye
|
|
CN101336890A
(zh)
|
2008-05-30 |
2009-01-07 |
济南基福医药科技有限公司 |
一种抗癌缓释凝胶注射剂
|
|
US8993615B2
(en)
*
|
2008-08-08 |
2015-03-31 |
The Johns Hopkins University |
Compositions and methods for treatment of neurodegenerative disease
|
|
WO2010030739A1
(en)
|
2008-09-10 |
2010-03-18 |
Abbott Laboratories |
Polyethylene glycol lipid conjugates and uses thereof
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
SG172938A1
(en)
|
2009-01-12 |
2011-08-29 |
Hadasit Med Res Service |
Tissue regeneration membrane
|
|
SG173167A1
(en)
|
2009-01-29 |
2011-08-29 |
Forsight Labs Llc |
Posterior segment drug delivery
|
|
WO2010091187A2
(en)
|
2009-02-04 |
2010-08-12 |
The Brigham And Women's Hospital, Inc. |
Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
|
|
AU2010213612B2
(en)
|
2009-02-12 |
2015-04-30 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
|
EP2403335B1
(en)
|
2009-03-03 |
2014-08-20 |
Alcon Research, Ltd. |
Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
|
|
GB0903810D0
(en)
|
2009-03-05 |
2009-04-22 |
Regentec Ltd |
Delivery system
|
|
WO2010114770A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
JP5820815B2
(ja)
|
2009-12-15 |
2015-11-24 |
インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ |
インプラントおよび生体分解性基準マーカー
|
|
WO2011106702A2
(en)
*
|
2010-02-25 |
2011-09-01 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
|
US20130071349A1
(en)
|
2010-03-02 |
2013-03-21 |
Allergan, Inc. |
Biodegradable polymers for lowering intraocular pressure
|
|
WO2011119777A2
(en)
*
|
2010-03-23 |
2011-09-29 |
The Johns Hopkins University |
Compositions and methods for treatment of neurodegenerative disease
|
|
US20110237686A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc |
Formulations and methods of use
|
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
|
US20120121718A1
(en)
|
2010-11-05 |
2012-05-17 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
US9327037B2
(en)
|
2011-02-08 |
2016-05-03 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
WO2012112674A2
(en)
*
|
2011-02-15 |
2012-08-23 |
The Johns Hopkins University |
Compounds and methods of use thereof for treating neurodegenerative disorders
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
CN103127096B
(zh)
*
|
2011-12-02 |
2015-11-25 |
杨子娇 |
吡咯基取代的吲哚类化合物在治疗青光眼病的应用
|
|
CN109200013A
(zh)
|
2011-12-05 |
2019-01-15 |
因赛普特有限责任公司 |
医用有机凝胶方法和组合物
|
|
US20140329913A1
(en)
|
2011-12-14 |
2014-11-06 |
The Johns Hopkins University |
Nanoparticles with enhanced mucosal penetration or decreased inflammation
|
|
RU2598627C2
(ru)
|
2012-01-19 |
2016-09-27 |
Дзе Джонс Хопкинс Юниверсити |
Композиции на основе наночастиц с улучшенным проникновением через слизистые оболочки
|
|
US10159743B2
(en)
|
2012-03-16 |
2018-12-25 |
The Johns Hopkins University |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
|
AU2013232297B2
(en)
|
2012-03-16 |
2016-01-14 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
|
US20140107025A1
(en)
|
2012-04-16 |
2014-04-17 |
Jade Therapeutics, Llc |
Ocular drug delivery system
|
|
JP6720443B2
(ja)
|
2012-05-03 |
2020-07-08 |
カラ ファーマシューティカルズ インコーポレイテッド |
改善された粘膜輸送を示す医薬用ナノ粒子
|
|
EP4008355A1
(en)
|
2012-05-03 |
2022-06-08 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
|
HK1208377A1
(en)
|
2012-05-04 |
2016-03-04 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
WO2013177367A2
(en)
*
|
2012-05-23 |
2013-11-28 |
The Johns Hopkins University |
Compounds and methods of use thereof for treating neurodegenerative disorders
|
|
CA2876311A1
(en)
*
|
2012-06-25 |
2013-12-19 |
Bayer Healthcare Llc |
Topical ophthalmological pharmaceutical composition containing sunitinib
|
|
BR112015005878A2
(pt)
*
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
nanopartículas terapêuticas compreendendo agente terapêutico e métodos de preparar e usar as mesmas
|
|
CN103848985B
(zh)
*
|
2012-11-30 |
2018-03-02 |
杨子剑 |
含有舒尼替尼类似物结构的新化合物以及制备方法和用途
|
|
AU2014248460B2
(en)
|
2013-04-01 |
2019-04-11 |
Allergan, Inc. |
Microsphere drug delivery system for sustained intraocular release
|
|
CN104208715B
(zh)
|
2013-05-31 |
2016-12-28 |
天津键凯科技有限公司 |
具有提高的药物生物活性的低分子量聚乙二醇药物结合物
|
|
JP5698882B1
(ja)
|
2013-06-18 |
2015-04-08 |
昭和電工株式会社 |
コンデンサ陽極体およびその製造方法
|
|
US10646027B2
(en)
|
2013-08-29 |
2020-05-12 |
Sayeeda Mazed |
Multifunctional personal care devices/apparatuses and compositions for hair or skin
|
|
US20160310417A1
(en)
|
2013-12-20 |
2016-10-27 |
Emory University |
Formulations and Methods For Targeted Ocular Delivery of Therapeutic Agents
|
|
KR101564401B1
(ko)
|
2014-04-10 |
2015-11-02 |
한국화학연구원 |
브린졸아마이드의 제조방법
|
|
JP2017524712A
(ja)
|
2014-08-13 |
2017-08-31 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
角膜同種移植片拒絶および新血管形成を予防するためのグルココルチコイドを負荷したナノ粒子
|
|
US20160106587A1
(en)
|
2014-10-16 |
2016-04-21 |
Incept, Llc |
Ocular gels or hydrogels and microinjectors
|
|
US10550187B2
(en)
|
2014-10-24 |
2020-02-04 |
Incept, Llc |
Extra luminal scaffold
|
|
KR20170117384A
(ko)
|
2014-12-10 |
2017-10-23 |
인셉트, 엘엘씨 |
히드로겔 약물 전달 임플란트
|
|
EP4445952A3
(en)
*
|
2014-12-15 |
2025-01-15 |
The Johns Hopkins University |
Sunitinib formulations and methods for use thereof in treatment of glaucoma
|
|
JP6479485B2
(ja)
|
2015-01-15 |
2019-03-06 |
大内新興化学工業株式会社 |
眼疾患治療用ナノ粒子製剤
|
|
EP3247406A1
(en)
|
2015-01-20 |
2017-11-29 |
The Johns Hopkins University |
Compositions for the sustained release of anti-glaucoma agents to control intraocular pressure
|
|
BR112017023762A2
(pt)
|
2015-05-05 |
2018-07-31 |
Psivida Us, Inc. |
formulações de depósito injetáveis
|
|
JP2018515529A
(ja)
|
2015-05-12 |
2018-06-14 |
インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ |
ハイドロゲルからの薬物送達
|
|
AU2016297642A1
(en)
|
2015-07-22 |
2018-02-15 |
Incept, Llc |
Coated punctal plug
|
|
BR112018010671A8
(pt)
|
2015-11-25 |
2019-02-26 |
Incept Llc |
dispositivos e métodos de distribuição de fármaco com mudança de forma
|